Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 28, 2009; 15(24): 3015-3024
Published online Jun 28, 2009. doi: 10.3748/wjg.15.3015
Figure 1
Figure 1 Distribution of liver failure etiologies in MARS-treated patients. 1192 MARS treatment cases and 188 patients were included in this study. Four patients were treated at two different time points, first due to the primary liver failure, and second for graft failure following LTX.
Figure 2
Figure 2 Kaplan-Meier cumulative survival for transplanted (A) and non-transplanted (B) MARS-treated patients with different causes of liver failure.